Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemomab Therapeutics (CMMB) Receivables (2017 - 2019)

Chemomab Therapeutics posted quarterly Receivables of $408000.0 for Q4 2019, down 88.08% year-on-year from $3.4 million in Q4 2018, and down 66.99% on a QoQ basis from $1.2 million in Q3 2019.

Chemomab Therapeutics (CMMB) has 3 years of Receivables data on file, last reported at $408000.0 in Q4 2019.

  • For the quarter ending Q4 2019, Receivables fell 88.08% year-over-year to $408000.0; the trailing twelve-month figure through Dec 2019 stood at $408000.0 (down 88.08% YoY), and the FY2019 full-year result was $408000.0, down 88.08% from the prior year.
  • Receivables for Q4 2019 stood at $408000.0, down from $1.2 million in the prior quarter.
  • Across five years, Receivables topped out at $3.4 million in Q4 2018 and bottomed at $408000.0 in Q4 2019.
  • The 3-year median for Receivables is $885000.0 (2019), against an average of $1.3 million.
  • The widest annual swing landed in 2018, when Receivables jumped 725.06%; it then slumped 88.08% in 2019.
  • A 3-year view of Receivables shows it stood at $415000.0 in 2017, then surged by 725.06% to $3.4 million in 2018, then plunged by 88.08% to $408000.0 in 2019.
  • The last three Receivables figures came in at $408000.0 (Q4 2019), $1.2 million (Q3 2019), and $885000.0 (Q2 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 13.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 4.15 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.00 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.73 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 883.96 Mn
10 Chemomab Therapeutics 959.23 Mn 948.86 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 408,000.00
Sep 30, 2019 1.24 Mn
Jun 30, 2019 885,000.00
Dec 31, 2018 3.42 Mn
Dec 31, 2017 415,000.00